Tag: biosimilar drugs

newdrug_690x380 cancer
April 9, 2015/Cancer/News & Insight

FDA OKs Zarxio as First Biosimilar Drug

Approval may spur competition, cost savings

BackPage 1 of 1Next
Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad